In Veritas Book Value Per Share vs. Market Capitalization
| IVME Stock | USD 0.0001 0.00 0.00% |
Book Value Per Share | First Reported 2010-12-31 | Previous Quarter (0.11) | Current Value (0.11) | Quarterly Volatility 0.01897418 |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 1.1 | 1.14 |
|
| |||||
| Operating Profit Margin | 1.71 | 0.87 |
|
|
For In Veritas profitability analysis, we use financial ratios and fundamental drivers that measure the ability of In Veritas to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well In Veritas Medical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between In Veritas's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of In Veritas Medical over time as well as its relative position and ranking within its peers.
IVME |
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of In Veritas. If investors know IVME will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about In Veritas listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.01) | Return On Assets (6.48) |
The market value of In Veritas Medical is measured differently than its book value, which is the value of IVME that is recorded on the company's balance sheet. Investors also form their own opinion of In Veritas' value that differs from its market value or its book value, called intrinsic value, which is In Veritas' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because In Veritas' market value can be influenced by many factors that don't directly affect In Veritas' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between In Veritas' value and its price as these two are different measures arrived at by different means. Investors typically determine if In Veritas is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, In Veritas' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
In Veritas Medical Market Capitalization vs. Book Value Per Share Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining In Veritas's current stock value. Our valuation model uses many indicators to compare In Veritas value to that of its competitors to determine the firm's financial worth. In Veritas Medical is currently regarded as number one stock in book value per share category among its peers. It also is currently regarded as number one stock in market capitalization category among its peers . At present, In Veritas' Book Value Per Share is projected to increase slightly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value In Veritas by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.IVME Market Capitalization vs. Book Value Per Share
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
In Veritas |
| = | (0.13) X |
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
In Veritas |
| = | 8.61 K |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
IVME Market Capitalization vs Competition
In Veritas Medical is currently regarded as number one stock in market capitalization category among its peers. Market capitalization of Financials industry is currently estimated at about 17.66 Billion. In Veritas adds roughly 8,605 in market capitalization claiming only tiny portion of equities under Financials industry.
In Veritas Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in In Veritas, profitability is also one of the essential criteria for including it into their portfolios because, without profit, In Veritas will eventually generate negative long term returns. The profitability progress is the general direction of In Veritas' change in net profit over the period of time. It can combine multiple indicators of In Veritas, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -2.4 M | -2.6 M | |
| Net Loss | -3.3 M | -3.5 M | |
| Income Before Tax | -3.3 M | -3.5 M | |
| Total Other Income Expense Net | -857.8 K | -900.7 K | |
| Net Loss | -3.3 M | -3.5 M | |
| Net Loss | -3.3 M | -3.5 M | |
| Change To Netincome | 1.4 M | 1 M | |
| Income Quality | 0.23 | 0.22 |
IVME Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on In Veritas. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of In Veritas position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the In Veritas' important profitability drivers and their relationship over time.
Use In Veritas in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if In Veritas position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in In Veritas will appreciate offsetting losses from the drop in the long position's value.In Veritas Pair Trading
In Veritas Medical Pair Trading Analysis
The ability to find closely correlated positions to In Veritas could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace In Veritas when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back In Veritas - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling In Veritas Medical to buy it.
The correlation of In Veritas is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as In Veritas moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if In Veritas Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for In Veritas can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your In Veritas position
In addition to having In Veritas in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Alternative Energy Thematic Idea Now
Alternative Energy
Large and mid-size companies, ETFs and funds that are either investing or directly involved in providing energy derived from sources not connected to fossil fuels, do not consume natural resources, and do not harm the environment. This includes wind power, nuclear and solar energy, biofuel, ethanol, hydrogen and others alternative sources of energy. The Alternative Energy theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Alternative Energy Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Risk vs Return Analysis. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
To fully project In Veritas' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of In Veritas Medical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include In Veritas' income statement, its balance sheet, and the statement of cash flows.